DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay
The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.
In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More
News items for the week of Jan. 30, 2023.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
Hologic Secures $19M BARDA Contract for COVID-19, Combination Assays
The money will support research and development to help the company gain FDA approval for its SARS-CoV-2 test and a SARS-CoV-2, influenza A and B, and RSV test.
DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
The Italian firm said the Liaison NES will help improve access to testing for bacterial and viral diseases through an easy-to-use instrument running lower cost assays.
Jul 30, 2021
Cepheid Gets $28M From BARDA for SARS-CoV-2 Tests
May 6, 2021
T2 Biosystems Q1 Revenues Nearly Triple
Apr 26, 2021
Sep 30, 2020